{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:41:15Z","timestamp":1791049275068,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["17GRNT33370012"],"award-info":[{"award-number":["17GRNT33370012"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2016C33096"],"award-info":[{"award-number":["2016C33096"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bbrc.2018.12.012","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T15:54:04Z","timestamp":1544802844000},"page":"1227-1232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting the Ca2+\/Calmodulin-dependent protein kinase II by Tetrandrine in human liver cancer cells"],"prefix":"10.1016","volume":"508","author":[{"given":"Tracy","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senlin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rucha","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5206-1038","authenticated-orcid":false,"given":"Ke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxian","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.12.012_bib1","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.4254\/wjh.v7.i26.2648","article-title":"Hepatocellular carcinoma: a comprehensive review","volume":"7","author":"Waller","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.bbrc.2018.12.012_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular carcinoma: a review","volume":"3","author":"Balogh","year":"2016","journal-title":"J.\u00a0Hepatocell. Carcinoma"},{"key":"10.1016\/j.bbrc.2018.12.012_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.12.012_bib4","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.3748\/wjg.v20.i15.4115","article-title":"Hepatocellular carcinoma review: current treatment, and evidence-based medicine","volume":"20","author":"Raza","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2018.12.012_bib5","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/516S4a","article-title":"Drug development: try and try again","volume":"516","author":"Scudellari","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.12.012_bib6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40265-018-0932-4","article-title":"Regorafenib: a review in hepatocellular carcinoma","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2018.12.012_bib7","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1074\/jbc.M407653200","article-title":"Calcium\/Calmodulin-dependent protein kinase II (CaMKII) localization acts in concert with substrate targeting to create spatial restriction for phosphorylation","volume":"280","author":"Tsui","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.12.012_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2014.00015","article-title":"CaMKIIdelta subtypes: localization and function","volume":"5","author":"Gray","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.12.012_bib9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/labinvest.3700658","article-title":"\u03b1-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression","volume":"87","author":"Yuan","year":"2007","journal-title":"Lab. Invest. J. Tech. Meth. Pathol."},{"key":"10.1016\/j.bbrc.2018.12.012_bib10","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1158\/0008-5472.CAN-07-2509","article-title":"Activated Ca2+\/calmodulin-dependent protein kinase II\u03b3 is a critical regulator of myeloid leukemia cell proliferation","volume":"68","author":"Si","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2018.12.012_bib11","doi-asserted-by":"crossref","first-page":"11725","DOI":"10.18632\/oncotarget.3955","article-title":"The emerging role of CaMKII in cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.12.012_bib12","doi-asserted-by":"crossref","first-page":"40800","DOI":"10.18632\/oncotarget.8315","article-title":"Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.12.012_bib13","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3892\/or.2013.2352","article-title":"Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2\/M phase","volume":"29","author":"Yu","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2018.12.012_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0024-3205(03)00266-2","article-title":"Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells","volume":"73","author":"Kuo","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2018.12.012_bib15","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.25817","article-title":"Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma","volume":"129","author":"Liu","year":"2011","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.bbrc.2018.12.012_bib16","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1016\/j.bmc.2016.06.039","article-title":"Novel FXR (farnesoid X receptor) modulators: potential therapies for cholesterol gallstone disease","volume":"24","author":"Yu","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2018.12.012_bib17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2005.10.029","article-title":"Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme","volume":"123","author":"Rosenberg","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.12.012_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000426","article-title":"Structure of the CaMKII\u03b4\/calmodulin complex reveals the molecular mechanism of CaMKII kinase activation","volume":"8","author":"Rellos","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbrc.2018.12.012_bib19","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1158\/1535-7163.MCT-13-0314","article-title":"Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca2+\/calmodulin-dependent protein kinase II","volume":"12","author":"Meng","year":"2013","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2018.12.012_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","article-title":"Tetrandrine \u2013 a molecule of wide bioactivity","volume":"125","author":"Bhagya","year":"2016","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbrc.2018.12.012_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2009.06.009","article-title":"Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice","volume":"287","author":"Wu","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2018.12.012_bib22","first-page":"1102","article-title":"Potential role of tetrandrine in cancer therapy","volume":"23","author":"Chen","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2018.12.012_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.5483\/BMBRep.2011.44.8.523","article-title":"Downregulation of ARFGEF1 and CAMK2B by promoter hypermethylation in breast cancer cells","volume":"44","author":"Kim","year":"2011","journal-title":"BMB Rep"},{"key":"10.1016\/j.bbrc.2018.12.012_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcb.21973","article-title":"Calcium\/calmodulin-dependent kinase II regulates notch-1 signaling in prostate cancer cells","volume":"106","author":"Mamaeva","year":"2009","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.bbrc.2018.12.012_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1751-2980.2011.00551.x","article-title":"Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer","volume":"13","author":"Li","year":"2012","journal-title":"J.\u00a0Digest. Dis."},{"key":"10.1016\/j.bbrc.2018.12.012_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn3192","article-title":"Mechanisms of CaMKII action in long-term potentiation","volume":"13","author":"Lisman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2018.12.012_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00395-018-0688-8","article-title":"Physiological and unappreciated roles of CaMKII in the heart","volume":"113","author":"Beckendorf","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbrc.2018.12.012_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0092-8674(00)80681-9","article-title":"A\u00a0role for CaMKII in T cell memory","volume":"100","author":"Bui","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.12.012_bib29","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.4049\/jimmunol.174.9.5583","article-title":"A\u00a0pivotal role for the multifunctional calcium\/calmodulin-dependent protein kinase II in T cells: from activation to unresponsiveness","volume":"174","author":"Lin","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2018.12.012_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccell.2017.06.001","article-title":"Stabilization of the c-myc protein by CAMKII\u03b3 promotes T cell lymphoma","volume":"32","author":"Gu","year":"2017","journal-title":"Cancer Cell"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1832655X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1832655X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T19:51:52Z","timestamp":1605642712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1832655X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0006291X1832655X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.012","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the Ca2+\/Calmodulin-dependent protein kinase II by Tetrandrine in human liver cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}